Medical AI reaches $15 billion valuation, but clinical effectiveness remains in question

A startup combining AI and medical literature OpenEvidence uses artificial intelligence to research and synthesize medical knowledge, providing answers supported by expert references. Following a $250 million funding round in September, the company was valued at $15 billion. The platform…














